KEMPF DAVID A 4

4 · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · Filed May 4, 2009

Insider Transaction Report

Form 4
Period: 2009-03-10
KEMPF DAVID A
DirectorCOO/CFO
Transactions
  • Purchase

    Series A Convertible Preferred Stock

    2009-04-15$1.00/sh+5,000$5,0005,000 total
  • Purchase

    Common Stock

    2009-03-10$0.49/sh+200$983,000 total(indirect: By IRA)
Holdings
  • Options

    Exercise: $1.00From: 2011-02-11Exp: 2019-02-11common stock (100,000 underlying)
    200,000
  • Common Stock

    (indirect: By IRA)
    2,800
  • Options

    Exercise: $1.00From: 2010-02-11Exp: 2019-02-11common stock (100,000 underlying)
    100,000
  • Options

    Exercise: $1.00From: 2012-02-11Exp: 2019-02-11common stock (100,000 underlying)
    300,000

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT